Your task is to predict the verdict of a claim based on the provided question-answer pair evidence. The possible labels are: 'Supported', 'Refuted', 'Not Enough Evidence', 'Conflicting Evidence/Cherrypicking'. Justify your answer using the provided evidence and select the correct label.

Claim: New Coronavirus antibody tests by Swiss pharmaceutical company Roche are 100% accurate.

Q1: What is the Roche test?
A1: Elecsys Anti-SARS-CoV-2 serology assay is intended for the detection of IgM and IgG
antibodies to SARS-CoV-2 in human serum and plasma.

Q2: Were the results 100% accurate?
A2: No. In conclusion, the Elecsys Anti-SARS-CoV-2 assay gave a specificity of 100% (95%CI
99.1-100) in this evaluation; the manufacturer reported a specificity of 99.81% (95%CI
99.65-99.91).
In this evaluation, the overall sensitivity of the Elecsys Anti-SARS-CoV-2 assay was
83.9% (95%CI 74.8-90.7). The sensitivity was 86.1% (95%CI 76.5-92.8) for samples
taken ≥14 since symptom onset and 86.7% (95%CI 76.8-93.4) for samples taken ≥21
days since symptom onset. The manufacturer reported a sensitivity of 100% (95%CI
88.1-100) for samples ≥14 days post-PCR confirmation.
user
justification: This claim is refuted. According to the QA pairs, the claim is correct in stating that Roche conducted new COVID-19 antibody tests. However, with the given data, there were confliciting test results not proving 100% accuracy. For example, the manufacter reported 100% sensitvity levels mean evaluated sensitivity levels were at 83.9%. Therefore, this claim is refuted.

verdict: 'Refuted'
assistant